UPDATE: Dicerna Announces License Agreement With Tekmira By: Benzinga via Benzinga November 17, 2014 at 08:09 AM EST Tekmira Pharmaceuticals Corporation (Nasdaq: TKMR) (TSX:TKM) a leading developer of RNA interference (RNAi) therapeutics, today ... Read More >> Related Stocks: Dicerna Pharmaceutic